WallStreetZenWallStreetZen

NASDAQ: BPTS
Biophytis Sa Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their BPTS stock forecasts and price targets.

Forecast return on equity

Is BPTS forecast to generate an efficient return?
Company
N/A
Industry
-87.2%
Market
19.16%

Forecast return on assets

Is BPTS forecast to generate an efficient return on assets?
Company
N/A
Industry
8.54%

BPTS revenue forecast

What is BPTS's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$4.6M
Avg 2 year Forecast
$18.2M
Avg 3 year Forecast
$35.0M

BPTS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BPTS$8.22N/AN/A
APVO$0.68N/AN/A
ALLR$1.43N/AN/A
VRAX$0.70N/AN/A
GRI$0.43N/AN/A

Biophytis Sa Stock Forecast FAQ

What is BPTS's revenue growth forecast for 2024-2026?

(NASDAQ: BPTS) Biophytis Sa's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.

Biophytis Sa's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast BPTS's revenue for 2024 to be $4,786,219,049, with the lowest BPTS revenue forecast at $4,786,219,049, and the highest BPTS revenue forecast at $4,786,219,049. On average, 1 Wall Street analysts forecast BPTS's revenue for 2025 to be $18,936,779,716, with the lowest BPTS revenue forecast at $18,936,779,716, and the highest BPTS revenue forecast at $18,936,779,716.

In 2026, BPTS is forecast to generate $36,416,884,070 in revenue, with the lowest revenue forecast at $36,416,884,070 and the highest revenue forecast at $36,416,884,070.

If you're new to stock investing, here's how to buy Biophytis Sa stock.

What is BPTS's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: BPTS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 8.54%.

What is BPTS's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: BPTS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.